謝易修Yih-Shou Hsieh吳蕙君Huei-Jiun生化暨生物科技研究所2026-10-289999-12-31https://handle.ncl.edu.tw/11296/66xqbshttps://scholars.csmu.edu.tw/handle/123456789/35235本研究主要觀察乳癌病人血清中及腫瘤組織中matrix metalloproteinase-2(MMP-2)和matrix metalloproteinase-9(MMP-9)蛋白表現,更進一步探討MMP-2與乳癌腫瘤組織大小的相關性。已有文獻報告證實MMP-2與乳癌發生的相關性。不過,有關乳癌病人血清中和組織中MMP-2活性與其腫瘤組織大小的相關性,目前還不清楚。在本研究以gelatin zymography和Enzyme-Linked Immunosorbent assay (ELISA)兩種方法,來測定90個乳癌病人MMP-2 和 MMP-9的濃度,其中包括60個腫瘤組織檢體和30個血清檢體。因MMP-2及MMP-9在基底膜的破壞扮演著重要角色,而且與癌症的侵襲及轉移最有關,實驗結果顯示乳癌腫瘤組織可觀察到ProMMP-2、activated MMP-2、proMMP-9 和 activated MMP-9的表現,且在乳癌腫瘤組織中MMP-2和MMP-9的表現均高於其正常組織(p<0.01)。更進一步以線性迴歸方法分析,其腫瘤的大小與MMP-2之濃度有正相關(R=0.55,p<0.0001),而且,同樣的結果也出現在血清檢體中(R=0.398,p=0.032)。另外也顯示在乳癌腫瘤有轉移的病人,其MMP-2的濃度明顯上升(p<0.05)。此外,在乳癌腫瘤發展之不同分期中,其MMP-2濃度也有不一樣之表現(p=0.006)。MMP-2濃度在血清及腫瘤組織中之表現,可反映出乳癌腫瘤侵襲及轉移之嚴重性,而根據腫瘤組織大小與MMP-2的相關性,許多MMP抑制劑亦可發展作為選擇性抑制腫瘤轉移的因子。The involvements of matrix metalloproteinase-2 (MMP-2) in the pathogenesis of breast cancers have been established. The aim of the present study was to determine the concentrations of MMP-2 in serum samples and tumor tissues of breast cancer patients.Gelatin zymography and ELISA were employed to measure MMP-2 and MMP-9 concentrations in 90 breast cancer patients, including 60 tissue samples and 30 serum samples.ProMMP-2, activated MMP-2, proMMP-9 and activated MMP-9 levels were significantly higher in tumor tissues than that of corresponding paired adjacent normal tissue of 60 breast cancer patients (p<0.05). Further linear regression analysis has showed that the tumor size positively correlated with MMP-2 level in tumor tissue samples (R=0.55,p<0.0001), as well as with that of in serum samples (R=0.398, p=0.032). In addition, further statistical analysis for clinic pathological parameters revealed that MMP-2 level was significantly increased in patients with metastasis (p<0.05). Furthermore, MMP-2 level was significantly different between tumor grades (p=0.006). Conclusions: MMP-2 levels in serum and tumor tissue might reflect the severity of invasion of breast cancer and various MMP inhibitors might be selectively used as potential anti-metastasis agents according to tumor size.乳癌病人其腫瘤組織大小與基質金屬蛋白水解酶的相關性研究thesis